MegumaGold Provides Update on Osprey Acquisition and Its Projects

Halifax, NS – April 14, 2020 – MegumaGold Corp. (CSE: NSAU) (OTC: NSAUF) (FWB: 2CM2) (“MegumaGold” or the “Company”) is pleased to provide the following updates on its on-going corporate and exploration activities. Osprey Gold Acquisition Update The Company continues its discussions with Osprey Gold Development Ltd. (“Osprey Gold”) regarding the proposed business combination transaction whereby the […]
Growing Number of Coronavirus Vaccines Under Development With 3 in Human Trials

Palm Beach, FL – April 14, 2020 – Many According to the World Health Organization (WHO) there are 70 coronavirus vaccines in development globally, with three candidates already being tested in human trials, as drugmakers race to find a cure for the deadly pathogen. Time magazine reported that the furthest along in the clinical process […]
AIkido Pharma Executes Exclusive World-Wide License to Broad Spectrum Antiviral Drug Platform, Includes Coronavirus

New York, NY – April 14, 2020 – AIkido Pharma Incorporated (Nasdaq: AIKI) today announced that it has secured an exclusive world-wide license for a broad spectrum antiviral drug platform. The licensed technology is a broadly acting pan-viral inhibitory compound with efficacy against multiple viral pathogens. The technology works to inhibit replication of multiple viruses […]
Positive Data Generated by Biosig Subsidiary ViralClear on Covid-19 Coronavirus Published in bioRxiv

>> Vicromax shown to decrease viral production of Covid -19 coronavirus by over 98% >> Article highlights recent work done in laboratory studies of Covid -19 with Vicromax(tm) at the Galveston Lational Laboratory at The University of Texas Medical Branch Westport, CT – April 14, 2020 – BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or […]